Free Consultation 215.567.2010

Pharmaceuticals

Members of our Pharmaceuticals team apply their legal expertise and advanced degrees in chemistry, pharmacy and other disciplines to provide our clients with legal services including:

  • Patentability Opinions
  • Freedom to Operate Opinions
  • Patent Preparation, Prosecution and Procurement
  • Representation in Post-Grant Proceedings in the U.S. Patent and Trademark Office, Including Interferences, Reexaminations, Inter Partes Review, and Post Grant Reviews
  • Due Diligence Studies
  • License counseling, negotiation and drafting
  • Alternative Dispute Resolution
  • Litigation, including patent infringement and ANDA litigation
  • ANDA development and design of finished dosage forms
  • Patent protection, enforcement and design around drug delivery forms and molecules

Related Representative Matters

  • Prepared memorandum on patent infringement damages for pharmaceutical client and assisted in decision which saved hundreds of millions of dollars
  • Successfully represented generic pharmaceutical company in ANDA litigation involving Niaspan® (niacin extended release)
  • In re ‘318 Patent Litigation, 578 F.Supp.2d 711 (D. Del. 2008), aff’d, 583 F.3d 1317 (Fed. Cir. 2009). Represented one of generic manufacturers in a patent infringement suit filed under 35 U.S.C. § 271(c)(2) regarding ANDA filing for an Alzheimer’s drug sold under the name Razdyne®/Reminyl® (galanthamine)
  • Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership v. Apotex, Inc., represented generic in ANDA litigation on Plavix® involving largest at risk launch in history
  • Roxane Labs Inc. v. Invagen Inc., successfully represented defendant generic company in transferring case from Ohio to NJ, defeated Preliminary Injunction, affirmed on appeal and obtained stipulation of non-infringement, affirmed on appeal, in suit by another generic regarding calcium acetate tablets (PhosLo® brand) and ultimately awarded client $2 million in attorney fees finding the case “exceptional”
  • Genzyme v. Pentech Pharmaceuticals, Inc. represented generic in ANDA litigation on Hectorol® invalidating 2 Orange Book listed patents, with third patent being delisted as a result of suit
  • Biovail Laboratories, Inc. v. Torpharm. Inc., successfully represented generic company in ANDA litigation involving Tiazac® (diltiazem hydrochloride)
  • Represented a leading multinational life sciences company in freedom-to-operate clearance searches and licensing opportunity identification
  • Represented a generic pharmaceutical company in an Inter Partes Reexamination proceeding which invalidated all the claims of the patent at issue
  • Represented a generic pharmaceutical company in an Ex Parte Reexamination proceeding in which the claim at issue was found invalid by the Patent Office

Philadelphia

1635 Market Street, 12th Floor
Philadelphia, Pennsylvania 19103-2212

215-567-2010 | 215-751-1142

View Map

Delaware

King Street Plaza - Suite 304. 800 N. King Street
Wilmington, Delaware 19801

302-544-9100 | 302-544-9103

View Map

Lehigh Valley

2030 Tilghman Street, Suite 201A
Allentown, Pennsylvania 18104-4399

610-255-7551 | 610-255-7542

View Map